FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay
FRANKFURT (Reuters) – Bayer (BAYGn.DE) shareholders on Tuesday voted in favour of ratifying the executive board’s business conduct during 2019, following a rebuke a year earlier.
At the annual shareholder meeting, 92.6% of the votes of shareholders that did not cast an abstain vote, were in favour of top management, with 7.4% giving a vote of no confidence.
Of all the votes cast in the ballot, 7.6% were abstain votes.
Reporting by Ludwig Burger